Results 261 to 270 of about 258,864 (309)

Ten tips to reduce fracture risk by non-pharmacologic interventions in CKD-associated osteoporosis. [PDF]

Clin Kidney J
Hansen D, Skou-Jørgensen H, Kanbay M, Fusaro M, Salomo L, Fleig S, Molsted S, Ryg J, Haarhaus M, Evenepoel P.   +9 more
europepmc   +1 more source

Physiologically based pharmacokinetic modeling and simulation of topiramate in populations with renal and hepatic impairment and considerations for drug–drug interactions

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 510-522, March 2025.
Abstract Topiramate (TPM) is a broad‐spectrum antiepileptic drug (AED) commonly prescribed for approved and off‐label uses. Routine monitoring is suggested for clinical usage of TPM in special population due to its broad side effect profile. Therefore, it is crucial to further explore its pharmacokinetic characteristics.
Shuqing Chen, Chaozhuang Shen, Yuchen Tian, Yuhe Peng, Jing Hu, Haitang Xie, Ping Yin   +6 more
wiley   +1 more source

<i>ECH1</i>-Deficiency-Mediated Polyunsaturated Fatty Acid Accumulation Promotes Vascular Smooth Muscle Cell Ferroptosis and Chronic-Kidney-Disease-Associated Plaque Vulnerability. [PDF]

Research (Wash D C)
Bi X, Zhou J, Liu L, Chen Z, Liang B, Tian S, Xiong J, Lan Q, Lv L, Li Y, Xiao T, He T, Zhang J, Nie L, Zhao J.   +14 more
europepmc   +1 more source

TyG-HDL Outperforms TyG Combined With Obesity Indicators in Predicting Chronic Kidney Disease Associated With High Fasting Blood Glucose Levels in the Chinese Elderly Population: A Two-Stage Study Based on GBD 2023 and CHARLS Data. [PDF]

Int J Endocrinol
Li L, Long L, Chen T, Tian X, Huang C, Chen Y, Ye S, Ye M, Leng J, Cao Z, Jiang Y, Bie M.   +11 more
europepmc   +1 more source

World Kidney Day 2026 in Africa: bridging environmental sustainability with the realities of kidney care. [PDF]

Ren Fail
Nzana VB, Kansiime G, Barday Z, Biikinga YW, Gawad MA, Davidson B, Nlandu YM.   +6 more
europepmc   +1 more source

Effects of Exercise Training on Experimental Chronic Kidney Disease: A Systematic Review and Meta-Analysis. [PDF]

Int J Mol Sci
Rehman M, Shah IA, Tsai KL, Lee SD, Wu BT.   +4 more
europepmc   +1 more source

Association between fibroblast growth factor 23 and coronary artery calcification in patients with chronic kidney disease: a meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Yi Y, Zhao Y, Wang H, Jiang X, Xuan Y.
europepmc   +1 more source

Association Between Serum Homocysteine and Chronic Kidney Disease Severity in Vietnamese Outpatients With Type 2 Diabetes: A Cross-Sectional Study. [PDF]

Endocrinol Diabetes Metab
Ho LN, Van Tran T, Tran TTT, Le NT, Quach LH, Thanh KM, Tran HN, Hoang HK, Tran HH, Le TQ.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

DAPA-CKD: Significant Victory for CKD with or without Diabetes

Trends in Endocrinology & Metabolism, 2021
Sodium glucose cotransporter 2 inhibitors (SGLT2i) have revolutionized the treatment of heart failure and diabetic kidney disease. The DAPA-CKD trial by Heerspink et al. evaluated primary kidney outcomes with dapagliflozin in both diabetic and non-diabetic patients and identified kidney protection by SGLT2i independent of diabetes mellitus.
Ankit B. Patel, Kavita Mistry, Ashish Verma   +2 more
openaire   +2 more sources